PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1182
https://www.valueinhealthjournal.com/article/S1098-3015(11)02744-6/fulltext
Section Title :
Cancer
Section Order :
1143
First Page :
A449
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02744-6&doi=10.1016/j.jval.2011.08.1182